Manus secures £1.2m to support launch of Parkinson’s Pen
Edinburgh, UK – Monday 25th January 2021: Edinburgh medtech company Manus Neurodynamica Limited (“Manus”), has closed a £1.2M funding round to support the launch of its digital pen which provides an early warning of Parkinson’s disease and other neurological conditions. With this latest funding secured, Manus is rolling-out its NeuroMotor PenTM later this year, initially focusing … Read more